Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Fanikos

Showing results (61-70 of 143) with videos related to

Pageof 15
Sort By:
The American Journal of Medicine|November 15, 2011
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levelsSteven Baroletti, Shelley Hurwitz, Nicole A S Conti, et al.
Journal of Medical Economics|February 16, 2022
Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the USJohn Fanikos, Joshua N Goldstein, Belinda Lovelace, et al.
Journal of Thrombosis and Thrombolysis|October 21, 2020
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experienceKatelyn W Sylvester, Caroline Wagner, Andrea Lewin, et al.
Research and Practice in Thrombosis and Haemostasis|May 11, 2022
Optimization of DOAC management services in a centralized anticoagulation clinicKatelyn W Sylvester, Alisia Chen, Andrea Lewin, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 26, 2007
Observations on the use of ready-to-use and point-of-care activated parenteral products in automated dispensing cabinets in U.S. hospitalsJohn Fanikos, Abbie Erickson, Kristin E Munz, et al.
The American Journal of Medicine|November 26, 2011
Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital dischargeJohn Fanikos, Amanda Rao, Andrew C Seger, et al.
The American Journal of Medicine|June 26, 2016
Evaluation of Dose-Reduced Direct Oral Anticoagulant TherapyMegan E Barra, John Fanikos, Jean M Connors, et al.
American Journal of Hematology|April 28, 2015
Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopeniaJames F Gilmore, Christopher D Adams, Rachel M Blum, et al.
The American Journal of Medicine|June 24, 2010
Adherence to pharmacological thromboprophylaxis orders in hospitalized patientsJohn Fanikos, Leslie Ann Stevens, Matthew Labreche, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
Consultant's Playbook: A Survey of Pharmacy Consultant Experiences Among Hospitals In the University HealthSystem ConsortiumDave Hicks, Bryan McCarthy, John Fanikos, et al.
Pageof 15

Showing results (61-70 of 143) with videos related to

Sort By:
Pageof 15
The American Journal of Medicine|November 15, 2011
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levelsSteven Baroletti, Shelley Hurwitz, Nicole A S Conti, et al.
Journal of Medical Economics|February 16, 2022
Cost-effectiveness of andexanet alfa versus four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-related intracranial hemorrhage in the USJohn Fanikos, Joshua N Goldstein, Belinda Lovelace, et al.
Journal of Thrombosis and Thrombolysis|October 21, 2020
Reasons for new patient warfarin referrals to an anticoagulant management service in 2019: a single institution experienceKatelyn W Sylvester, Caroline Wagner, Andrea Lewin, et al.
Research and Practice in Thrombosis and Haemostasis|May 11, 2022
Optimization of DOAC management services in a centralized anticoagulation clinicKatelyn W Sylvester, Alisia Chen, Andrea Lewin, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 26, 2007
Observations on the use of ready-to-use and point-of-care activated parenteral products in automated dispensing cabinets in U.S. hospitalsJohn Fanikos, Abbie Erickson, Kristin E Munz, et al.
The American Journal of Medicine|November 26, 2011
Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital dischargeJohn Fanikos, Amanda Rao, Andrew C Seger, et al.
The American Journal of Medicine|June 26, 2016
Evaluation of Dose-Reduced Direct Oral Anticoagulant TherapyMegan E Barra, John Fanikos, Jean M Connors, et al.
American Journal of Hematology|April 28, 2015
Evaluation of a multi-target direct thrombin inhibitor dosing and titration guideline for patients with suspected heparin-induced thrombocytopeniaJames F Gilmore, Christopher D Adams, Rachel M Blum, et al.
The American Journal of Medicine|June 24, 2010
Adherence to pharmacological thromboprophylaxis orders in hospitalized patientsJohn Fanikos, Leslie Ann Stevens, Matthew Labreche, et al.
P & T : a Peer-Reviewed Journal for Formulary Management|January 7, 2014
Consultant's Playbook: A Survey of Pharmacy Consultant Experiences Among Hospitals In the University HealthSystem ConsortiumDave Hicks, Bryan McCarthy, John Fanikos, et al.
Pageof 15